Legend Biotech Corporation
LEGN
$34.18
-$0.52-1.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -125.32M | -18.20M | -59.79M | -144.82M | -62.21M |
| Total Depreciation and Amortization | 5.16M | 5.00M | 4.84M | 4.87M | 4.67M |
| Total Amortization of Deferred Charges | 314.00K | 366.00K | 885.00K | 482.00K | 499.00K |
| Total Other Non-Cash Items | 61.42M | -189.00K | -36.64M | 55.39M | -1.25M |
| Change in Net Operating Assets | -17.39M | 11.37M | 106.23M | -11.57M | -2.56M |
| Cash from Operations | -75.82M | -1.65M | 15.52M | -95.65M | -60.85M |
| Capital Expenditure | -2.07M | -3.42M | -6.25M | -4.35M | -5.38M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 331.14M | -692.21M | -389.90M | 411.85M | -203.70M |
| Cash from Investing | 329.08M | -695.63M | -396.15M | 407.51M | -209.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.16M | -1.16M | -758.00K | 304.00K | -1.72M |
| Issuance of Common Stock | 5.41M | 2.12M | 1.59M | 621.00K | 2.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.25M | 955.00K | 831.00K | 925.00K | 961.00K |
| Foreign Exchange rate Adjustments | 524.00K | 9.00K | -343.00K | 1.45M | -784.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 258.02M | -696.32M | -380.14M | 314.24M | -269.74M |
